Some interesting news that should be of interest to us HEBers:
Hemispherx Board of Directors Authorizes Multimillion Dollar Expansion of Its FDA Licensed Manufacturing FacilitiesIncreases Capability to Expand Alferon LDO(TM) and Ampligen(R) for Various Influenza-Based Clinical and Commercial Production
PHILADELPHIA, Sep 16, 2009 (GlobeNewswire via COMTEX) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") today announced that its Board of Directors has just approved up to $4.4 Million (U.S.) for full engineering studies, capital improvements, system upgrades, and introduction of building management systems to enhance production of three products: Alferon N(R) (its FDA licensed biologic), Alferon LDO and Ampligen(R). Alferon LDO and Ampligen(R) (Poly I : Poly C12U) are experimental therapeutics being developed for multiple clinical indications including prevention, prophylaxis and treatment of both seasonal and pandemic influenza. LINK
FDA approval finally coming, my man???
Subscribe to:
Post Comments (Atom)
myman, should i sell ctic to buy heb? i have not much fund. and i have more shares in ctic in my whole portfolio.
ReplyDeleteHey, babe uske, you should email me at mymanheb@gmail.com as I'm not sure if you want to discuss all this in public.
ReplyDeleteIf you can, keep money in both HEB and CTIC. They are both legitimate prospects for making money and HEB could literally get approval any day now. Both stocks could potentially be at $10 per share or more at some point in the future.
But email me so we can talk more in detail, my man.
I really can't answer that question for you because only you know what you are looking for and how much money you have to invest. Are you looking to make money in the short-term or are you willing to wait and plan for down the road, my man? How many shares do you have in HEB and CTIC?
I would be happy to give you my advice, my man.